Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

zelenoleucel

A preparation of allogeneic multi-tumor-associated antigen (MultiTAA)-specific T lymphocytes, with potential immunomodulating and antineoplastic activities. Upon administration, zelenoleucel may target and kill tumor cells expressing the TAAs.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:allogeneic MultiTAA-specific T lymphocytes MT-401
donor-derived multi-tumor-associated antigen-specific T cells
Code name:MT 401
MT-401
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search